“A £180 million government fund to help innovative small and medium sized enterprises (SMEs) and academics to develop solutions to healthcare challenges will open for applications at the end of April.
The Biomedical Catalyst is a key element of the Strategy for Life Sciences launched by the Prime Minister in December last year. It will see the Medical Research Council (MRC) and the Technology Strategy Board working together to take the best British medical breakthroughs through to commercial success.
The Biomedical Catalyst will be open to SMEs and academics, and will accept proposals from sectors that have the potential to provide significant positive healthcare and economic impact. It will support the development of innovative technologies emerging from partnerships between clinicians, academics and industry.
Three categories of grant awards will be available through the Biomedical Catalyst scheme – feasibility, early stage and late stage. Any SME or academic undertaking research and development, either individually or working in collaboration, may apply and applications will be accepted at any time. Individual grants to businesses will range from a maximum of £150,000 for feasibility awards to £3 million for early and late stage awards.” – Mersey Bio News 12April2012
